Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow
Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow is organized by Physicians' Education Resource, LLC (PER).
Release Date: January 26, 2023
Expiration Date: January 26, 2024
Description:
This Community Practice Connection™ program provides a review of key highlights from recent studies in the management of myeloproliferative neoplasm (MPNs), including myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET). This multimedia activity is ideal for community-based clinicians, focusing on key takeaways and practical advice for managing patients with these heme malignancies and using written summaries supplemented by interviews with expert faculty. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
- Determine factors that inform personalized treatment decisions in patients with MF, PV, and ET based on genetics, risk stratification, and symptom burden
- Outline the mechanistic rationale for the application of current and emerging therapeutic approaches for the management of MPNs
- Assess the efficacy and safety profiles of current and emerging therapeutic strategies in MPNs across lines of therapy
- Integrate recent clinical trial evidence and guidelines to individualize decisions among patients with MPNs, including management of treatment-related toxicities